Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients.

MLA

Tedesco-Silva, Helio, et al. “Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients.” Transplantation Direct, vol. 2, no. 4, Mar. 2016, p. e69. EBSCOhost, https://doi.org/10.1097/TXD.0000000000000579.

APA

Tedesco-Silva, H., Peddi, V. R., Sánchez-Fructuoso, A., Marder, B. A., Russ, G. R., Diekmann, F., Flynn, A., Hahn, C. M., Li, H., Tortorici, M. A., & Schulman, S. L. (2016). Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients. Transplantation Direct, 2(4), e69. https://doi.org/10.1097/TXD.0000000000000579

Chicago

Tedesco-Silva, Helio, V Ram Peddi, Ana Sánchez-Fructuoso, Brad A Marder, Graeme R Russ, Fritz Diekmann, Alison Flynn, et al. 2016. “Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients.” Transplantation Direct 2 (4): e69. doi:10.1097/TXD.0000000000000579.